Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
500.00    0.00 (0.00%)
Bid:
499.80
Ask:
500.50
Spread: 0.70 (0.14%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARDS

28 Mar 2013 14:05

RNS Number : 1634B
Chemring Group PLC
28 March 2013
 



FOR IMMEDIATE RELEASE 28 MARCH 2013

CHEMRING GROUP PLC

ALLOY SURFACES AND KILGORE FLARES AWARDED $26 MILLION COUNTERMEASURES CONTRACTS BY THE US DEPARTMENT OF DEFENSE

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiaries, Alloy Surfaces Company, Inc. and Kilgore Flares Company LLC, have been awarded contracts worth $26 million for the manufacture of M211, M206, MJU-7A/B and MJU-10/B decoy devices for the US Army and the US Air Force. Deliveries under the contracts are scheduled to begin in June 2013 and will continue into 2015. The M211 decoy order is valued at $6 million, and will be produced at Alloy Surfaces. The M206, MJU-7A/B and MJU-10/B contracts are valued at $20 million, and will be produced at Kilgore Flares.

Mark Papworth, Chief Executive of Chemring, commented: "We are very pleased to receive these contracts from the US Army and the US Air Force, which demonstrates their continued confidence and trust in our countermeasures. We are very proud to deliver the highest quality infra-red decoys to the US Department of Defense and our international customers."

The US Army and US Air Force use these decoys to protect all of their helicopters, and transport and fighter aircraft against man-portable air defense systems, commonly known as MANPADS.

-ENDS-

Chemring Group PLC

Rupert Pittman - Group Director of Communications and Investor Relations

01489 881880 / rupertp@chemring.co.uk

MHP Communications

Andrew Jaques / James White

0203 128 8100

Notes to Editors:

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over sixty countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. Alloy Surfaces and Kilgore Flares are industry leaders in the design, development, and production of F-22, JSF and covert multi-spectral special material decoys. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEEFDAFDSEID
Date   Source Headline
9th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20248:09 amRNSTransaction in Own Shares
1st Feb 20249:59 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20244:16 pmRNSNotice of AGM
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20241:11 pmRNSHolding(s) in Company
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20242:27 pmRNSHolding(s) in Company (Corrected)
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20243:58 pmRNSHolding(s) in Company
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 202310:54 amRNSBlock listing Interim Review
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20233:20 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20234:22 pmRNSDirector/PDMR Shareholding
13th Dec 20234:16 pmRNSDirector/PDMR Shareholding
13th Dec 202312:20 pmRNSDirector/PDMR Shareholding
13th Dec 202312:19 pmRNSDirector/PDMR Shareholding
13th Dec 202312:19 pmRNSDirector/PDMR Shareholding
13th Dec 202312:15 pmRNSDirector/PDMR Shareholding
13th Dec 202312:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.